´ëÇÑÁ¾¾ç³»°úÇÐȸ 2019 HCC Symposium: New horizons for the multimodal treatment of HCC : 2019-06-22
±³À°ÀÏÀÚ : 2019-06-22
±³À°Àå¼Ò : ¸£¸Þ¸£µð¾Ó¼¿ï, ¼¼ÀÜ·ë (2Ãþ)
±³À°ÁÖÁ¦ : 2019 HCC Symposium: New horizons for the multimodal treatment of HCC
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ : ksmo@ksmo.or.kr
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï - ȸ¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ¿¬±¸¿ø : 30,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü : 10,000 ¾÷ü ¹× ±âŸ : 50,000 »çÀüµî·Ï - ºñȸ¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø : 60,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü : 30,000 ¾÷ü ¹× ±âŸ : 70,000 ÇöÀåµî·Ï-ȸ¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ¿¬±¸¿ø : 40,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü : 20,000 ¾÷ü ¹× ±âŸ : 60,000 ÇöÀåµî·Ï - ºñȸ¿ø ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø : 70,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/°øº¸ÀÇ/±ºÀÇ°ü : 40,000 ¾÷ü ¹× ±âŸ : 80,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 09:00~09:30 What are the histopathologic features of hepatocellular carcinoma Á¤Àº¼±(ÀºÆò¼º¸ðº´¿ø º´¸®°ú)
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 09:30~10:00 HCC staging: conventional and tailored approach ±è¼Ò¿¬(¼¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 10:00~10:30 Radiation therapy with immune modulation effect in HCC ¹ÚÈñö(»ï¼º¼¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)
ÈÞ½Ä 06-22 10:30~10:40 Coffee break ()
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 10:40~11:00 Optimal timing for systemic chemotherapy in TACE refractory HCC patients ÀüÈ«Àç(ºÐ´çÂ÷º´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 11:00~11:20 What's the optimal sequential therapy in unresectable HCC among the emerging options? À¯Ã¢ÈÆ(¼¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 11:20~11:50 Immunotherapy for HCC: What¡¯s Next? Anthony El- Khoueiry(Norris Comprehensive Cancer Center, USA)
ÈÞ½Ä 06-22 11:50~12:00 Coffee break ()
±³À°½Ã°£ 06-22 ¼¼ÀÜ·ë 12:00~12:30 Optimizing window of opportunity to prolong OS in HCC Anthony El- Khoueiry(Norris Comprehensive Cancer Center, USA)